Stop TB Partnership

Newly available tests for rapid TB diagnosis: what you need to know

15 May 2020, Geneva, Switzerland – Three products have recently been made available to support TB programmes’ efforts to reach UN TB targets to detect and treat 40 million people with TB by 2022, including 3.5 million children, as well as 1.5 million people with drug-resistant TB. All three tests offer opportunities for multiplexing, with menus of tests for other diseases available, including COVID-19 tests.

Read More →

TB and COVID-19 modelling study updates

The Stop TB Partnership recently released a modeling study showing a devastating effect of COVID-19 pandemic on TB response. Length of quarantine, movement restrictions and disruption of TB services could spell disaster for hundreds of thousands at risk. The world could see 6.3 million more TB cases and 1.4 million more TB deaths by 2025.

Read More →

New report shows devastating effect of COVID-19 pandemic on TB response

6.3 million more people ill with TB and 1.4 million more TB deaths by 2025; Length of quarantine, movement restrictions and disruption of TB services could spell disaster for hundreds of thousands at risk.

Read More →

Strategic Initiative to Find the Missing People with TB newsletter

The Stop TB Partnership released the first edition of its quarterly newsletter for 2020 detailing the progress of the Global Fund’s Strategic Initiative to Find the Missing People with TB.

Read More →

Virtual Innovation Spotlights on health tech solutions for TB and COVID-19

To support country programs, communities, people affected by TB, and partners during the COVID-19 pandemic, the Stop TB Partnership’s Strategic Initiatives & Innovative Financing (SIIF) Team, as part of its Re-Imagining TB Care initiative, is organising a series of Virtual Innovation Spotlights to share various health tech solutions that can be used to:

Read More →

TB response is heavily impacted by the COVID-19 pandemic

The Stop TB Partnership Secretariat organized a rapid assessment of the impact the COVID-19 pandemic and related measures have on the TB response in 20 high burden countries that represent 54% of the global TB burden, through interviews with National TB Programs (NTPs) and focal points based on a set of open-ended questions. Similarly, the Global Coalition of TB Activists (GCTA) did a worldwide survey through their network of members collecting answers from TB civil society and communities from 16 countries, with data updated regularly.

Read More →

Xpert Xpress SARS-CoV-2 cartridge now available from Stop TB Partnership’s Global Drug Facility

27 March 2020, Geneva, Switzerland – The Stop TB Partnership’s Global Drug Facility (GDF) has expanded its Diagnostics Catalog to include a new test for novel coronavirus SARS-CoV-2, the virus that causes COVID-19 disease. The Xpert Xpress SARS-CoV-2 test cartridges are now available at US$19.80 per cartridge from the manufacturer, Cepheid. For the full listing, see the GDF Diagnostics Catalog.

Read More →

TB REACH Wave 8 now open for proposals

The Stop TB Partnership’s TB REACH launched its Wave 8 round of funding to focus on engaging private providers in the TB response.

Read More →

World TB Day 2020 in the times of COVID-19

Join the virtual - worldwide - TB town hall on 24 March!

Read More →

Presenting the TB affected communities and civil society delegations to the Stop TB Partnership Board

In a first for the Stop TB Partnership, 33 TB champions representing TB Affected Communities, Developing Country NGOs and Developed Country NGOs constituencies, have been selected to support the affected community and civil society Board Members.

Read More →

Page 1 of 36 · Total posts: 10

1 2 Last→